Michelle Se Won Min
Associate Professor, Dermatology
School of Medicine
School of Medicine
Director of Rheumatologic-Dermatology, Dermatology
School of Medicine
School of Medicine
Director of Medical Dermatology, Dermatology
School of Medicine
School of Medicine
Director of Special Project (Scribe Pilot), Dermatology
School of Medicine
School of Medicine
M.D., Boston University School of Medicine
M.S., University of Pennsylvania, 2010, Chemistry
Brigham and Women's Hospital, Harvard Medical School, 2021, Dermatology-Rheumatology Fellowship
Icahn School of Medicine, Mount Sinai, 2020, Dermatology Residency
Icahn School of Medicine, Mount Sinai, 2015, Biologics/Infusion Dermatology Fellowship
B.A., University of Pennsylvania, 2010, Biochemistry, Biology
M.S., University of Pennsylvania, 2010, Chemistry
Brigham and Women's Hospital, Harvard Medical School, 2021, Dermatology-Rheumatology Fellowship
Icahn School of Medicine, Mount Sinai, 2020, Dermatology Residency
Icahn School of Medicine, Mount Sinai, 2015, Biologics/Infusion Dermatology Fellowship
B.A., University of Pennsylvania, 2010, Biochemistry, Biology
University of California, Irvine
118 Medical Surge 1
Irvine, CA 92697
118 Medical Surge 1
Irvine, CA 92697
Research Interests
Dermatology-Rheumatology
Publications
PUBLICATIONS
1. Vleugels RA, Paik JJ, Bauer Ventura I, Mangold AR, Gandiga PC, Haemel A, Chinoy H, Hussain YM, Sivakumar K, Zoltan G, Lee EB, Bozan F, Hsu CY, Femia A, Dimachkie MM, Min MS, Mozaffar T, Charles-Schoeman C, Fernandez DR, Onajin O, Marques R, Marder G, Ernste F, Schiopu E, Sluzevich J, Pearson D, Lindsey S, Luggen M, Bubb MR, Boh E, Maganti R, Heinlen L, Shaw KS, Cascino MD, Mudd PN Jr, Vencovsky J, Fernandez AP, Fiorentino D, Christopher-Stine L, Werth VP, Aggarwal R; VALOR Investigators. A Phase 3 Trial of Brepocitinib in Dermatomyositis. N Engl J Med. 2026 May 14;394(19):1883-1893. doi: 10.1056/NEJMoa2503531.
2. Choe S, Patel AB, Phong C, Yale K, Golbari NM, Zachary CB, Min MS. From plaques to pigment: Eruptive lentiginosis in resolving psoriatic plaques after biologic therapy. JAAD Case Rep. 2025 Oct 25;67:216-225. doi: 10.1016/j.jdcr.2025.09.045.
3. Kasheri E, Smith J, Min MS. Glucagon-like peptide-1 receptor agonists may decrease biologic initiation in hidradenitis suppurativa: A TriNetX retrospective analysis. J Am Acad Dermatol. 2026 Apr;94(4):1331-1332.
4. Shire S, McFeeters J, Kim H, Min MS, Han JH, Nelson CA, Piguet V, Williams JA, Kaffenberger BH. Validation of the Physician Global Assessment × Maximum Diameter (PGAMAX) as a severity assessment tool for pyoderma gangrenosum. J Am Acad Dermatol. 2026 Apr;94(4):1252-1254.
5. Shah KS, Min MS. Association between keloids and cardiovascular disease in Black and Asian individuals. JAAD Int. 2025 Jun 30;22:40-42. doi: 10.1016/j.jdin.2025.06.003. PMID: 40727640; PMCID: PMC12302852.
6. Kim RW, Mesinkovska NA, Min MS. Limitations in insurance coverage for management of alopecia, a response to Brinks et al's letter. J Am Acad Dermatol. 2025 Oct;93(4):e153-e154.
7. Gordon ER, Shah KS, Chand S, Lee B, Smith J, Min MS. Concurrent Psoriasis and Dermatomyositis: Retrospective Analysis and Literature Review. JEADV Clinical Practice. 2025: 205-210. https://doi.org/10.1002/jvc2.70247
8. Vikram E, Arora J, Woll J, Di Tomasso PM, Kassels A, Min M. Disparities in Dermatomyositis Management Based on Insurance Coverage. (2025). SKIN The Journal of Cutaneous Medicine. 2025: 9(4), 2479-2483. https://doi.org/10.25251/mqg7f422
9. Min MS, Vikram EP. Rheumatologic Dermatology and Breast Cancer: What Every Dermatologist Should Know. Aligning Dermatology and Oncology | Breast Cancer Awareness. Dermatology Times. October 2025: 46(8).
10. Schwarzenberger K, Min MS. What can dermatologists do to advocate for expanded insurance coverage of wigs for patients with scarring types of alopecia? Clinical Applications Forum. AAD DermWorld. 2025 Nov 1.
11. Kassels AC, Arora JS, Min MS. Evaluating Skin of Color Representation for Connective Tissue Diseases in Dermatology Textbooks. Int J Dermatol. 2025 Oct;64(10):1949-1951.
12. Kim RW, McClain W, Mesinkovska NA, Min MS. Legislative efforts to expand insurance coverage of wigs for individuals with medical causes of alopecia. J Am Acad Dermatol. 2025 Mar;92(3):663-665.
13. Arora JS, Kesler A, Min MS. A global retrospective study identifies higher rates of pernio in individuals with connective tissue disease. J Am Acad Dermatol. 2025 Mar;92(3):636-640.
14. Messele F, Horton L, Sharma AN, Min MS, Rojek NW, Linden KG. Relapsing toxic epidermal necrolysis following COVID-19. JAAD Case Rep. 2024 Jul 31;53:23-26.
15. Arora JS, Mahadevan A, Smith J, Min MS. Risk of Developing Hematologic Malignancy in Patients with Autoimmune and Inflammatory Skin Diseases. JAMA Dermatol. 2026 Feb;94(2):588-592.
16. Arora JS, Kincaid CM, Sharma AN, Mesinkovska NA, Min MS. Characterization of scalp involvement in dermatomyositis based on myositis-specific antibody subsets. J Am Acad Dermatol. 2024 Aug 23:S0190-9622(24)02718-X. Online ahead of print.
17. Forouzan P, Raffi J, Doan LT, Min MS. Reactive Lobular Panniculitis in the Setting of Mpox (Monkeypox) Infection. Am J Dermatopathol. 2024 Jul 16. doi: 10.1097/DAD.0000000000002795. Online ahead of print.
18. Elghazzawy MB, Nassir S, Arora JS, Min MS. A retrospective cohort study investigating cutaneous vasculitis in the setting of COVID-19 notes higher rates of IgA vasculitis. J Am Acad Dermatol. 2024;91(4):757-759.
19. Leigh RM, Horton L, Lee BA, Min MS. Recurrent erythema multiforme in the setting of COVID-19 infection and oral candidiasis: A case for dysregulation of the T helper 17/interleukin 17 axis. JAAD Case Rep. 2025 Dec 29;69:70-73.
20. Kassels A, Min MS, Kraus CN. Population-level retrospective study associating lichen sclerosus with autoimmune dermatologic and rheumatologic conditions. J Am Acad Dermatol. 2024;91(3):588-589.
21. Messele F, Horton L, Sharma AN, Min MS, Rojek NW, Linden KG. Relapsing toxic epidermal necrolysis following COVID-19. JAAD Case Rep. 2024;53:23-26.
22. Min MS. Dermatology Cases for Board Review: 200 Cases with Q&A and Detailed Rationales. McGraw Hill; 2023.
23. Min MS*, Goldman N, Mazori DR, Guo LN, Vleugels RA, LaChance, AH. Hyaluronidase injections for oral microstomia: a study in systemic sclerosis and mixed connective tissue disease. JAMA Dermatol. 2023 Dec 1;159(12):1393-1395.
*Corresponding authors
24. Min MS, Mazori DR, Lee MS, Merola JF, Vleugels RA, Cobos G, LaChance AH. Successful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional Dupilumab. J Drugs Dermatol. 2023 Dec 1;22(12):1220-1222.
25. Elsanadi R, Yale K, Rojek N, Zhao D, Lee B, Min MS. A case of interstitial granulomatous dermatitis presenting in a patient with necrotizing sarcoid granulomatosis. JAAD Case Rep. 2023 Jun 14:38:92-95.
26. O'Connell KA, Schaefer M, Atzmony L, Vleugels RA, Choate K, LaChance AH, Min MS. Clinical features in adults with acquired cutis laxa: a retrospective review. Br J Dermatol. 2023 May 24;188(6):800-816.
27. Min MS*, Alsarheed A, Kassamali B, Mazori DR, Schaefer M, Merola JF, Cobos G, LaChance AH, Vleugels RA*. Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from two academic medical centers. J Am Acad Dermatol. 2022;86(2):423-425.
Co-corresponding authors
28. Ganske IM, Cappitelli AT, Langa OC, Min M, Torok KS, Dedeoglu F, Vleugels RA. Pilot use of 3-dimensional photography to aid clinical decision-making in craniofacial morphea. JAAD Case Rep. 2022 Jun 7;25:100-103.
29. Min MS*, Mazori DR, Kassamali B, Cobos G, Ho A, LaChance AH, Vleugels RA*. Treatment with mycophenolate mofetil for salt-and-pepper dyspigmentation caused by autoimmune sclerosing disease. JAMA Dermatol. 2022;158(3):327-329.
*Co-corresponding authors
30. Min MS, Kassamali B, Mazori DR, Gizelis O, Schaefer M, Ho A, Merola JF, Cobos G, LaChance AH, Vleugels RA. Lack of association between tumor necrosis factor-a inhibitor use and exacerbation of lupus erythematosus: a retrospective cohort study. J Am Acad Dermatol. 2022;86(5):1180-1182.
31. Min MS*, Kus K, Wei N, Kassamali B, Faletsky A, Mostaghimi A, Lebwohl MG. Evaluating the role of histopathology in diagnosis pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study. Br J Dermatol. 2022;186(6):1035-1037.
*Corresponding author
32. Min MS, Kassamali B, Mazori DR, Vleugels RA, Merola JF, Cobos G, LaChance AH. The catch-22 of limited Food and Drug Administration approval for connective tissue disease therapies. J Am Acad Dermatol. 2021;85(2):517-519.
33. Ghatnekar S, Shah N, Min MS, Mazori DR, LaChance AH, Vleugels RA, Nambudiri VE. Clinical features and eosinophilia in pityriasis rubra pilaris: a multicenter cohort. J Am Acad Dermatol. 2022;86(4):907-909.
34. Kassamali B, Villa-Ruiz C, Mazori DR, Min M, Cobos GA, LaChance AH. Characterizing top educational TikTok videos by dermatologists in response to "TikTok and dermatology: An opportunity for public health engagement". J Am Acad Dermatol. 2021;85(1):e27-e28.
35. Kassamali B, Kus KJB, Min MS, Cobos GA, LaChance AH, Mazori DR. Importance of nose wires in fabric face masks in reply to: “Diagnostic and management considerations for “maskne” in the era of COVID-19”. J Am Acad Dermatol. 2021;157(7):880-882.
36. Mazori DR, Min MS, Kassamali B, Brichta L, Cobos GA, Merola JF, Vleugels RA, LaChance AH. Novel use of tofacitinib 2% ointment for periorbital discoid lupus erythematosus. JAMA Dermatol. 2021 Jul 1;157(7):880-882.
37. Kassamali B, Kus KJB, Min MS, Villa-Ruiz C, Cobos GA, Merola JF, Vleugels RA, Mazori DR, LaChance AH. Characteristics and treatment of silicone granulomas: A retrospective multicenter cohort of 21 patients. JAAD Int. 2021;3:111-114.
38. O’Connell KA, Min MS*, LaChance AH*. Bright red macules of the lower legs. JAMA Dermatol. 2021;157(9):1118-1119.
*Co-senior and co-corresponding authors
39. Kassamali B, Desai S, Min M, Mazori D, Villa-Ruiz C, Kus K, Cobos G, Merola J, LaChance A, Vleugels R. OnabotulinumtoxinA for systemic sclerosis-associated Raynaud's phenomenon: A multi-institutional study on accessibility and effectiveness. J Drugs Dermatol. 2021;20(11):1257-1259.
40. Mazori DR, Kassamali B, Min MS, Schaefer M, LaChance AH, Sperling AS, Vleugels RA. Characteristics and outcomes of eosinophilic fasciitis-associated monoclonal gammopathy. JAMA Dermatol. 2021;157(12):1508-1509.
41. Mazori DR, Min MS, Schaefer M, Imadojemu SE, Ho AW, Cobos GA, Vleugels RA. Treatment of the lupus pernio variant of sarcoidosis with oral tofacitinib. JAMA Dermatol. Submitted 2021.
42. Mazori DR, Alsarheed A, Min MS, Schaefer M, Ho AW, Cobos GA, Vleugels RA. Anti-MDA5 dermatomyositis following hand-foot-and-mouth disease: Insights into potential disease pathogenesis. JAMA Dermatol. Submitted 2021.
43. Min MS, Kurtzman DJB, Vleugels RA, Callen JP. Clinical Features: Cancer-Associated Myositis (CAM). Book Chapter. Submitted 2021.
44. Lee MS, Klebanov N, Quattrochi B, Murphy G, Min M*, LaChance A*. A 44-year-old woman with violaceous, ulcerated plaques in a dermatomal distribution. New England Dermatological Society. 2021: Case XIII.
*Co-senior authors
45. Min MS, Wu J, He H, Sanz-Cabanillas JL, Del Duca E, Zhang N, Renert-Yuval Y, Pavel AB, Lebwohl M, Guttman-Yassky E. Granuloma annulare skin profile shows activation of Th1, Th2, and JAK pathways. J Am Acad Dermatol. 2020;83(1):63-70.
46. Villa-Ruiz C, Kassamali B, Mazori DR, Min M, Cobos G, LaChance A. Overview of TikTok's most viewed dermatologic content and assessment of its reliability. J Am Acad Dermatol. 2021;85(1):273-274.
47. Fenner J, Min MS, Liu S, Silverberg N. A case of neonatal pemphigus vulgaris with co-existing BP180 autoantibodies. Pediatr Derm. 2020;37(1):241-243.
48. Min M, Anvekar R, Wu J, Liu S, Phelps R. Lupus profundus recalcitrant to systemic therapy. ADC 2019 Patient Viewing Casebook. 2019:12-13.
49. Min M, Ryu B, Alani R. Cell cycle activators and tumor suppressors that correlate with melanoma progression. SKIN The Journal of Cutaneous Medicine. 2019;3(2):144.
50. Min MS, Damstetter E, Chen AYY. Autoimmune blistering disorders in the setting of human immunodeficiency virus infection. Int J Womens Dermatol. 2018;4(3):159-165.
51. Khattri S, Goldblum O, Solotkin K, Amir Y, Min MS, Ridenour T, Yang FE, Lebwohl M. Early onset of clinical improvement with ixekizumab in a randomized, open-label study of patients with moderate-to-severe plaque psoriasis. J Clin Aesthet Dermatol. 2018;11(5):33-37.
52. Min MS*, Phelps R, Levitt J. Recurrent lupus profundus-like panniculitis associated with streptococcal throat infections in an immunocompetent child. JAAD Case Rep. 2018;4(4):359-361.
*Corresponding author
53. Min MS, Al-Haseni, Succaria F, Goldberg L, Lerne A, Sahni D. Anaplastic large cell lymphoma localized to the left breast years after radiotherapy for breast cancer. Dermatol Online J. 2018;24(1):pii:13030/qt7940069z.
54. Min MS*, Yao J, Chee N, Sapadin AN, Shim-Chang H. Xanthogranulomuatous reaction to trametinib for metastatic malignant melanoma. Cutis. 2018;102(4):283-286.
*Corresponding author
55. Mansouri Y, Amir Y, Min M, Khanna R, Huang R, Suarez-Farinas M, Lebwohl M. Impact of temperature on injection-related pain caused by subcutaneous administration of ustekinumab: a three-arm crossover open-label randomized controlled trial. SKIN The Journal of Cutaneous Medicine. 2017;1(3):117-127.
56. Min MS, Lebwohl M. Treatment of recalcitrant granuloma annulare with adalimumab: A single-center, observational study. J Am Acad Dermatol. 2016;74(1):127-33.
57. Guttman-Yassky E, Ungar B, Noda S, Suprun M, Shroff A, Dutt R, Khattri S, Min M, Mansouri Y, Zheng X, Estrada YD, Singer GK, Suarez-Farinas M, Krueger JG, Lebwohl MG. Extensive alopecia areata is reversed by IL-12/IL-23 p40 cytokine antagonism. J Allergy Clin Immunol. 2016;137(1):301-304.
58. Min MS, Shroff A, Rose S, Lebwohl M, Guttman-Yassky E. Ustekinumab as therapy for psoriasis in a 2-year-old girl. J Eur Acad Dermatol Venereol. 2016;30(11):e109-e110.
59. Min MS*, Fischer R, Fournier J. Unilateral erythema nodosum following norethindrone acetate, ethinyl estradiol, ferrous fumarate combination therapy. Case Rep Obstet Gynecol. 2016;2016:5726416.
*Corresponding author
60. Hwang S, Kim H-E, Min M, Raghunathan R, Panova I, Munshi R, Ryu B. Epigenetic silencing of SPINT2 promotes cancer cell motility via HGF-MET pathway activation in melanoma. J Invest Dermatol. 2015;135(9):2283-91.
61. Min MS, Yao J, Kim SJ. Development of a reticular rash in a febrile woman: An unusual cutaneous presentation of angioimmunoblastic T-cell lymphoma. J Am Acad Dermatol Case Reports. 2015; 1(3):160-2.
62. Yu Z, Goodman LD, Shieh SY, Min M, Teng X, Zhu Y, Bonin NM. A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL 1. Hum Mol Genet. 2015;24(4):954-62.
63. Xue K*, Min M*, Gelfand M, Ortega R. Anesthesiology through the lens of traditional Chinese medicine. Bull Anesth Hist. 2014;32(1):16-20.
*Co-first authors
1. Vleugels RA, Paik JJ, Bauer Ventura I, Mangold AR, Gandiga PC, Haemel A, Chinoy H, Hussain YM, Sivakumar K, Zoltan G, Lee EB, Bozan F, Hsu CY, Femia A, Dimachkie MM, Min MS, Mozaffar T, Charles-Schoeman C, Fernandez DR, Onajin O, Marques R, Marder G, Ernste F, Schiopu E, Sluzevich J, Pearson D, Lindsey S, Luggen M, Bubb MR, Boh E, Maganti R, Heinlen L, Shaw KS, Cascino MD, Mudd PN Jr, Vencovsky J, Fernandez AP, Fiorentino D, Christopher-Stine L, Werth VP, Aggarwal R; VALOR Investigators. A Phase 3 Trial of Brepocitinib in Dermatomyositis. N Engl J Med. 2026 May 14;394(19):1883-1893. doi: 10.1056/NEJMoa2503531.
2. Choe S, Patel AB, Phong C, Yale K, Golbari NM, Zachary CB, Min MS. From plaques to pigment: Eruptive lentiginosis in resolving psoriatic plaques after biologic therapy. JAAD Case Rep. 2025 Oct 25;67:216-225. doi: 10.1016/j.jdcr.2025.09.045.
3. Kasheri E, Smith J, Min MS. Glucagon-like peptide-1 receptor agonists may decrease biologic initiation in hidradenitis suppurativa: A TriNetX retrospective analysis. J Am Acad Dermatol. 2026 Apr;94(4):1331-1332.
4. Shire S, McFeeters J, Kim H, Min MS, Han JH, Nelson CA, Piguet V, Williams JA, Kaffenberger BH. Validation of the Physician Global Assessment × Maximum Diameter (PGAMAX) as a severity assessment tool for pyoderma gangrenosum. J Am Acad Dermatol. 2026 Apr;94(4):1252-1254.
5. Shah KS, Min MS. Association between keloids and cardiovascular disease in Black and Asian individuals. JAAD Int. 2025 Jun 30;22:40-42. doi: 10.1016/j.jdin.2025.06.003. PMID: 40727640; PMCID: PMC12302852.
6. Kim RW, Mesinkovska NA, Min MS. Limitations in insurance coverage for management of alopecia, a response to Brinks et al's letter. J Am Acad Dermatol. 2025 Oct;93(4):e153-e154.
7. Gordon ER, Shah KS, Chand S, Lee B, Smith J, Min MS. Concurrent Psoriasis and Dermatomyositis: Retrospective Analysis and Literature Review. JEADV Clinical Practice. 2025: 205-210. https://doi.org/10.1002/jvc2.70247
8. Vikram E, Arora J, Woll J, Di Tomasso PM, Kassels A, Min M. Disparities in Dermatomyositis Management Based on Insurance Coverage. (2025). SKIN The Journal of Cutaneous Medicine. 2025: 9(4), 2479-2483. https://doi.org/10.25251/mqg7f422
9. Min MS, Vikram EP. Rheumatologic Dermatology and Breast Cancer: What Every Dermatologist Should Know. Aligning Dermatology and Oncology | Breast Cancer Awareness. Dermatology Times. October 2025: 46(8).
10. Schwarzenberger K, Min MS. What can dermatologists do to advocate for expanded insurance coverage of wigs for patients with scarring types of alopecia? Clinical Applications Forum. AAD DermWorld. 2025 Nov 1.
11. Kassels AC, Arora JS, Min MS. Evaluating Skin of Color Representation for Connective Tissue Diseases in Dermatology Textbooks. Int J Dermatol. 2025 Oct;64(10):1949-1951.
12. Kim RW, McClain W, Mesinkovska NA, Min MS. Legislative efforts to expand insurance coverage of wigs for individuals with medical causes of alopecia. J Am Acad Dermatol. 2025 Mar;92(3):663-665.
13. Arora JS, Kesler A, Min MS. A global retrospective study identifies higher rates of pernio in individuals with connective tissue disease. J Am Acad Dermatol. 2025 Mar;92(3):636-640.
14. Messele F, Horton L, Sharma AN, Min MS, Rojek NW, Linden KG. Relapsing toxic epidermal necrolysis following COVID-19. JAAD Case Rep. 2024 Jul 31;53:23-26.
15. Arora JS, Mahadevan A, Smith J, Min MS. Risk of Developing Hematologic Malignancy in Patients with Autoimmune and Inflammatory Skin Diseases. JAMA Dermatol. 2026 Feb;94(2):588-592.
16. Arora JS, Kincaid CM, Sharma AN, Mesinkovska NA, Min MS. Characterization of scalp involvement in dermatomyositis based on myositis-specific antibody subsets. J Am Acad Dermatol. 2024 Aug 23:S0190-9622(24)02718-X. Online ahead of print.
17. Forouzan P, Raffi J, Doan LT, Min MS. Reactive Lobular Panniculitis in the Setting of Mpox (Monkeypox) Infection. Am J Dermatopathol. 2024 Jul 16. doi: 10.1097/DAD.0000000000002795. Online ahead of print.
18. Elghazzawy MB, Nassir S, Arora JS, Min MS. A retrospective cohort study investigating cutaneous vasculitis in the setting of COVID-19 notes higher rates of IgA vasculitis. J Am Acad Dermatol. 2024;91(4):757-759.
19. Leigh RM, Horton L, Lee BA, Min MS. Recurrent erythema multiforme in the setting of COVID-19 infection and oral candidiasis: A case for dysregulation of the T helper 17/interleukin 17 axis. JAAD Case Rep. 2025 Dec 29;69:70-73.
20. Kassels A, Min MS, Kraus CN. Population-level retrospective study associating lichen sclerosus with autoimmune dermatologic and rheumatologic conditions. J Am Acad Dermatol. 2024;91(3):588-589.
21. Messele F, Horton L, Sharma AN, Min MS, Rojek NW, Linden KG. Relapsing toxic epidermal necrolysis following COVID-19. JAAD Case Rep. 2024;53:23-26.
22. Min MS. Dermatology Cases for Board Review: 200 Cases with Q&A and Detailed Rationales. McGraw Hill; 2023.
23. Min MS*, Goldman N, Mazori DR, Guo LN, Vleugels RA, LaChance, AH. Hyaluronidase injections for oral microstomia: a study in systemic sclerosis and mixed connective tissue disease. JAMA Dermatol. 2023 Dec 1;159(12):1393-1395.
*Corresponding authors
24. Min MS, Mazori DR, Lee MS, Merola JF, Vleugels RA, Cobos G, LaChance AH. Successful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional Dupilumab. J Drugs Dermatol. 2023 Dec 1;22(12):1220-1222.
25. Elsanadi R, Yale K, Rojek N, Zhao D, Lee B, Min MS. A case of interstitial granulomatous dermatitis presenting in a patient with necrotizing sarcoid granulomatosis. JAAD Case Rep. 2023 Jun 14:38:92-95.
26. O'Connell KA, Schaefer M, Atzmony L, Vleugels RA, Choate K, LaChance AH, Min MS. Clinical features in adults with acquired cutis laxa: a retrospective review. Br J Dermatol. 2023 May 24;188(6):800-816.
27. Min MS*, Alsarheed A, Kassamali B, Mazori DR, Schaefer M, Merola JF, Cobos G, LaChance AH, Vleugels RA*. Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from two academic medical centers. J Am Acad Dermatol. 2022;86(2):423-425.
Co-corresponding authors
28. Ganske IM, Cappitelli AT, Langa OC, Min M, Torok KS, Dedeoglu F, Vleugels RA. Pilot use of 3-dimensional photography to aid clinical decision-making in craniofacial morphea. JAAD Case Rep. 2022 Jun 7;25:100-103.
29. Min MS*, Mazori DR, Kassamali B, Cobos G, Ho A, LaChance AH, Vleugels RA*. Treatment with mycophenolate mofetil for salt-and-pepper dyspigmentation caused by autoimmune sclerosing disease. JAMA Dermatol. 2022;158(3):327-329.
*Co-corresponding authors
30. Min MS, Kassamali B, Mazori DR, Gizelis O, Schaefer M, Ho A, Merola JF, Cobos G, LaChance AH, Vleugels RA. Lack of association between tumor necrosis factor-a inhibitor use and exacerbation of lupus erythematosus: a retrospective cohort study. J Am Acad Dermatol. 2022;86(5):1180-1182.
31. Min MS*, Kus K, Wei N, Kassamali B, Faletsky A, Mostaghimi A, Lebwohl MG. Evaluating the role of histopathology in diagnosis pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study. Br J Dermatol. 2022;186(6):1035-1037.
*Corresponding author
32. Min MS, Kassamali B, Mazori DR, Vleugels RA, Merola JF, Cobos G, LaChance AH. The catch-22 of limited Food and Drug Administration approval for connective tissue disease therapies. J Am Acad Dermatol. 2021;85(2):517-519.
33. Ghatnekar S, Shah N, Min MS, Mazori DR, LaChance AH, Vleugels RA, Nambudiri VE. Clinical features and eosinophilia in pityriasis rubra pilaris: a multicenter cohort. J Am Acad Dermatol. 2022;86(4):907-909.
34. Kassamali B, Villa-Ruiz C, Mazori DR, Min M, Cobos GA, LaChance AH. Characterizing top educational TikTok videos by dermatologists in response to "TikTok and dermatology: An opportunity for public health engagement". J Am Acad Dermatol. 2021;85(1):e27-e28.
35. Kassamali B, Kus KJB, Min MS, Cobos GA, LaChance AH, Mazori DR. Importance of nose wires in fabric face masks in reply to: “Diagnostic and management considerations for “maskne” in the era of COVID-19”. J Am Acad Dermatol. 2021;157(7):880-882.
36. Mazori DR, Min MS, Kassamali B, Brichta L, Cobos GA, Merola JF, Vleugels RA, LaChance AH. Novel use of tofacitinib 2% ointment for periorbital discoid lupus erythematosus. JAMA Dermatol. 2021 Jul 1;157(7):880-882.
37. Kassamali B, Kus KJB, Min MS, Villa-Ruiz C, Cobos GA, Merola JF, Vleugels RA, Mazori DR, LaChance AH. Characteristics and treatment of silicone granulomas: A retrospective multicenter cohort of 21 patients. JAAD Int. 2021;3:111-114.
38. O’Connell KA, Min MS*, LaChance AH*. Bright red macules of the lower legs. JAMA Dermatol. 2021;157(9):1118-1119.
*Co-senior and co-corresponding authors
39. Kassamali B, Desai S, Min M, Mazori D, Villa-Ruiz C, Kus K, Cobos G, Merola J, LaChance A, Vleugels R. OnabotulinumtoxinA for systemic sclerosis-associated Raynaud's phenomenon: A multi-institutional study on accessibility and effectiveness. J Drugs Dermatol. 2021;20(11):1257-1259.
40. Mazori DR, Kassamali B, Min MS, Schaefer M, LaChance AH, Sperling AS, Vleugels RA. Characteristics and outcomes of eosinophilic fasciitis-associated monoclonal gammopathy. JAMA Dermatol. 2021;157(12):1508-1509.
41. Mazori DR, Min MS, Schaefer M, Imadojemu SE, Ho AW, Cobos GA, Vleugels RA. Treatment of the lupus pernio variant of sarcoidosis with oral tofacitinib. JAMA Dermatol. Submitted 2021.
42. Mazori DR, Alsarheed A, Min MS, Schaefer M, Ho AW, Cobos GA, Vleugels RA. Anti-MDA5 dermatomyositis following hand-foot-and-mouth disease: Insights into potential disease pathogenesis. JAMA Dermatol. Submitted 2021.
43. Min MS, Kurtzman DJB, Vleugels RA, Callen JP. Clinical Features: Cancer-Associated Myositis (CAM). Book Chapter. Submitted 2021.
44. Lee MS, Klebanov N, Quattrochi B, Murphy G, Min M*, LaChance A*. A 44-year-old woman with violaceous, ulcerated plaques in a dermatomal distribution. New England Dermatological Society. 2021: Case XIII.
*Co-senior authors
45. Min MS, Wu J, He H, Sanz-Cabanillas JL, Del Duca E, Zhang N, Renert-Yuval Y, Pavel AB, Lebwohl M, Guttman-Yassky E. Granuloma annulare skin profile shows activation of Th1, Th2, and JAK pathways. J Am Acad Dermatol. 2020;83(1):63-70.
46. Villa-Ruiz C, Kassamali B, Mazori DR, Min M, Cobos G, LaChance A. Overview of TikTok's most viewed dermatologic content and assessment of its reliability. J Am Acad Dermatol. 2021;85(1):273-274.
47. Fenner J, Min MS, Liu S, Silverberg N. A case of neonatal pemphigus vulgaris with co-existing BP180 autoantibodies. Pediatr Derm. 2020;37(1):241-243.
48. Min M, Anvekar R, Wu J, Liu S, Phelps R. Lupus profundus recalcitrant to systemic therapy. ADC 2019 Patient Viewing Casebook. 2019:12-13.
49. Min M, Ryu B, Alani R. Cell cycle activators and tumor suppressors that correlate with melanoma progression. SKIN The Journal of Cutaneous Medicine. 2019;3(2):144.
50. Min MS, Damstetter E, Chen AYY. Autoimmune blistering disorders in the setting of human immunodeficiency virus infection. Int J Womens Dermatol. 2018;4(3):159-165.
51. Khattri S, Goldblum O, Solotkin K, Amir Y, Min MS, Ridenour T, Yang FE, Lebwohl M. Early onset of clinical improvement with ixekizumab in a randomized, open-label study of patients with moderate-to-severe plaque psoriasis. J Clin Aesthet Dermatol. 2018;11(5):33-37.
52. Min MS*, Phelps R, Levitt J. Recurrent lupus profundus-like panniculitis associated with streptococcal throat infections in an immunocompetent child. JAAD Case Rep. 2018;4(4):359-361.
*Corresponding author
53. Min MS, Al-Haseni, Succaria F, Goldberg L, Lerne A, Sahni D. Anaplastic large cell lymphoma localized to the left breast years after radiotherapy for breast cancer. Dermatol Online J. 2018;24(1):pii:13030/qt7940069z.
54. Min MS*, Yao J, Chee N, Sapadin AN, Shim-Chang H. Xanthogranulomuatous reaction to trametinib for metastatic malignant melanoma. Cutis. 2018;102(4):283-286.
*Corresponding author
55. Mansouri Y, Amir Y, Min M, Khanna R, Huang R, Suarez-Farinas M, Lebwohl M. Impact of temperature on injection-related pain caused by subcutaneous administration of ustekinumab: a three-arm crossover open-label randomized controlled trial. SKIN The Journal of Cutaneous Medicine. 2017;1(3):117-127.
56. Min MS, Lebwohl M. Treatment of recalcitrant granuloma annulare with adalimumab: A single-center, observational study. J Am Acad Dermatol. 2016;74(1):127-33.
57. Guttman-Yassky E, Ungar B, Noda S, Suprun M, Shroff A, Dutt R, Khattri S, Min M, Mansouri Y, Zheng X, Estrada YD, Singer GK, Suarez-Farinas M, Krueger JG, Lebwohl MG. Extensive alopecia areata is reversed by IL-12/IL-23 p40 cytokine antagonism. J Allergy Clin Immunol. 2016;137(1):301-304.
58. Min MS, Shroff A, Rose S, Lebwohl M, Guttman-Yassky E. Ustekinumab as therapy for psoriasis in a 2-year-old girl. J Eur Acad Dermatol Venereol. 2016;30(11):e109-e110.
59. Min MS*, Fischer R, Fournier J. Unilateral erythema nodosum following norethindrone acetate, ethinyl estradiol, ferrous fumarate combination therapy. Case Rep Obstet Gynecol. 2016;2016:5726416.
*Corresponding author
60. Hwang S, Kim H-E, Min M, Raghunathan R, Panova I, Munshi R, Ryu B. Epigenetic silencing of SPINT2 promotes cancer cell motility via HGF-MET pathway activation in melanoma. J Invest Dermatol. 2015;135(9):2283-91.
61. Min MS, Yao J, Kim SJ. Development of a reticular rash in a febrile woman: An unusual cutaneous presentation of angioimmunoblastic T-cell lymphoma. J Am Acad Dermatol Case Reports. 2015; 1(3):160-2.
62. Yu Z, Goodman LD, Shieh SY, Min M, Teng X, Zhu Y, Bonin NM. A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL 1. Hum Mol Genet. 2015;24(4):954-62.
63. Xue K*, Min M*, Gelfand M, Ortega R. Anesthesiology through the lens of traditional Chinese medicine. Bull Anesth Hist. 2014;32(1):16-20.
*Co-first authors
Professional Societies
American Academy Dermatology, Member 2017 – Present
Women’s Dermatologic Society, Member 2017 – 2021
American Society for Dermatologic Surgery, Member 2017– 2021
American Society for Laser Medicine and Surgery, 2017-2021
Rheumatologic Dermatology Society, Member 2020 – Present
Gold Humanism Honor Society, Member 2015 – Present
American Medical Association, Member 2011 – Present
Dermatologic Society of Greater New York, Member 2017 – 2020
Massachusetts Medical Society, Member 2011 – 2021
Orange County Dermatologic Society, 2022-Present
California Dermatology Society, 2024 - Present
Graduate Programs
Dermatology
Link to this profile
https://faculty.uci.edu/profile/?facultyId=7026
https://faculty.uci.edu/profile/?facultyId=7026
Last updated
05/19/2026
05/19/2026